Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer.
Matrone A, Prete A, Nervo A, Ragni A, Agate L, Molinaro E, Giani C, Valerio L, Minaldi E, Piovesan A, Elisei R.
Matrone A, et al. Among authors: elisei r.
J Endocrinol Invest. 2021 Oct;44(10):2139-2151. doi: 10.1007/s40618-020-01491-3. Epub 2021 Feb 17.
J Endocrinol Invest. 2021.
PMID: 33594641